FDA Approves Abbott's Next-Generation Stent

Abbott Labs (NYSE: ABT  ) announced in a press release late last week  that the Food and Drug Administration has approved the company's next-generation Xience Xpedition drug-eluting coronary stent.

The company is planning  for an immediate launch of the Xpedition with the approval in hand. The product gained CE Mark approval in Europe several months ago, and Abbott relied on similar data that won that recognition -- data compiled from 100 studies and thousands of patients -- to gain the FDA thumbs up.

Abbott's executive vice president of Medical Devices, Dr. John Capek, explained  the Xpedition's role in the company's future in the release, saying:

The launch of XIENCE Xpedition in the United States will advance Abbott's worldwide market-leading position in drug eluting stents. ... With its redesigned stent delivery system and a full matrix of sizes, XIENCE Xpedition provides physicians with a comprehensive, trusted option to treat a broad range of patients with coronary artery disease.

The approval marks the first  regulatory victory for Abbott since the company completed the spinoff of its pharmaceuticals business on Jan. 1.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2183347, ~/Articles/ArticleHandler.aspx, 10/1/2014 8:58:15 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement